Santen Pharmaceutical Co., Ltd. (TYO:4536)
Japan · Delayed Price · Currency is JPY 1,770.50
+17.00 (0.97%)
Oct 29, 2026, 3:30 PM JST
Santen Pharmaceutical Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Santen Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ¥2,378. The average 1-year stock price forecast is 34.30% higher than the current stock price, while the lowest is ¥1,900 (+7.31%) and the highest is ¥2,800 (+58.15%).
Price Target: ¥2,378 (+34.30%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Jul 14, 2026.
Analyst Ratings
The average analyst rating for Santen Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst UBS No rating | UBS | Buy Maintains ¥2,300 → ¥2,450 | Buy | Maintains | ¥2,300 → ¥2,450 | +38.38% | Jul 14, 2026 |
Financial Forecast
Revenue This Year
304.03B
from 291.62B
Increased by 4.25%
Revenue Next Year
312.43B
from 304.03B
Increased by 2.76%
EPS This Year
120.54
from 113.80
Increased by 5.92%
EPS Next Year
135.14
from 120.54
Increased by 12.11%
Financial currency is JPY.